Literature DB >> 23224145

MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion.

Jessica Bockhorn1, Kathy Yee, Ya-Fang Chang, Aleix Prat, Dezheng Huo, Chika Nwachukwu, Rachel Dalton, Simo Huang, Kaitlin E Swanson, Charles M Perou, Olufunmilayo I Olopade, Michael F Clarke, Geoffrey L Greene, Huiping Liu.   

Abstract

Metastasis remains a significant challenge in treating cancer. A better understanding of the molecular mechanisms underlying metastasis is needed to develop more effective treatments. Here, we show that human breast tumor biomarker miR-30c regulates invasion by targeting the cytoskeleton network genes encoding twinfilin 1 (TWF1) and vimentin (VIM). Both VIM and TWF1 have been shown to regulate epithelial-to-mesenchymal transition. Similar to TWF1, VIM also regulates F-actin formation, a key component of cellular transition to a more invasive mesenchymal phenotype. To further characterize the role of the TWF1 pathway in breast cancer, we found that IL-11 is an important target of TWF1 that regulates breast cancer cell invasion and STAT3 phosphorylation. The miR-30c-VIM/TWF1 signaling cascade is also associated with clinical outcome in breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224145      PMCID: PMC3583223          DOI: 10.1007/s10549-012-2346-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  24 in total

Review 1.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

2.  The two ADF-H domains of twinfilin play functionally distinct roles in interactions with actin monomers.

Authors:  Pauli J Ojala; Ville O Paavilainen; Maria K Vartiainen; Roman Tuma; Alan G Weeds; Pekka Lappalainen
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

3.  Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6.

Authors:  J J Schuringa; A T Wierenga; W Kruijer; E Vellenga
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

4.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

5.  MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11.

Authors:  Jessica Bockhorn; Rachel Dalton; Chika Nwachukwu; Simo Huang; Aleix Prat; Kathy Yee; Ya-Fang Chang; Dezheng Huo; Yujia Wen; Kaitlin E Swanson; Tyler Qiu; Jun Lu; Seo Young Park; M Eileen Dolan; Charles M Perou; Olufunmilayo I Olopade; Michael F Clarke; Geoffrey L Greene; Huiping Liu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

7.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

Authors:  Matthias Ernst; Meri Najdovska; Dianne Grail; Therese Lundgren-May; Michael Buchert; Hazel Tye; Vance B Matthews; Jane Armes; Prithi S Bhathal; Norman R Hughes; Eric G Marcusson; James G Karras; Songqing Na; Jonathon D Sedgwick; Paul J Hertzog; Brendan J Jenkins
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 8.  The war on cancer.

Authors:  M B Sporn
Journal:  Lancet       Date:  1996-05-18       Impact factor: 79.321

9.  Principles of microRNA-target recognition.

Authors:  Julius Brennecke; Alexander Stark; Robert B Russell; Stephen M Cohen
Journal:  PLoS Biol       Date:  2005-03       Impact factor: 8.029

10.  GeneSet2miRNA: finding the signature of cooperative miRNA activities in the gene lists.

Authors:  Alexey V Antonov; Sabine Dietmann; Philip Wong; Dominik Lutter; Hans W Mewes
Journal:  Nucleic Acids Res       Date:  2009-05-06       Impact factor: 16.971

View more
  56 in total

1.  miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway.

Authors:  Ravand Samaeekia; Valery Adorno-Cruz; Jessica Bockhorn; Ya-Fang Chang; Simo Huang; Aleix Prat; Nahun Ha; Golam Kibria; Dezheng Huo; Hui Zheng; Rachel Dalton; Yuhao Wang; Grigoriy Y Moskalenko; Huiping Liu
Journal:  Clin Cancer Res       Date:  2016-07-19       Impact factor: 12.531

2.  IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model.

Authors:  H Kitamura; Y Onodera; S Murakami; T Suzuki; H Motohashi
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

3.  Effect of the miR-96-5p inhibitor and mimic on the migration and invasion of the SW480-7 colorectal cancer cell line.

Authors:  Pei Yuan He; Wai Kien Yip; Mohd Faisal Jabar; Norhafizah Mohtarrudin; Noraini Mohd Dusa; Heng Fong Seow
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

4.  Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.

Authors:  Jiwei Huang; Xiaoying Yao; Jin Zhang; Baijun Dong; Qi Chen; Wei Xue; Dongming Liu; Yiran Huang
Journal:  Cancer Sci       Date:  2013-10-27       Impact factor: 6.716

Review 5.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.

Authors:  Ravi Kasiappan; Dheeran Rajarajan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

6.  MicroRNA-30c-1-3p is a silencer of the pregnane X receptor by targeting the 3'-untranslated region and alters the expression of its target gene cytochrome P450 3A4.

Authors:  Thaveechai Vachirayonstien; Bingfang Yan
Journal:  Biochim Biophys Acta       Date:  2016-04-13

7.  Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models.

Authors:  Jessica Bockhorn; Aleix Prat; Ya-Fang Chang; Xia Liu; Simo Huang; Meng Shang; Chika Nwachukwu; Maria J Gomez-Vega; J Chuck Harrell; Olufunmilayo I Olopade; Charles M Perou; Huiping Liu
Journal:  Cancer Res       Date:  2014-10-22       Impact factor: 12.701

8.  mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice.

Authors:  Julian Dymacek; Brandi N Snyder-Talkington; Dale W Porter; Robert R Mercer; Michael G Wolfarth; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  Toxicol Sci       Date:  2014-12-18       Impact factor: 4.849

9.  miR-30 family promotes migratory and invasive abilities in CD133(+) pancreatic cancer stem-like cells.

Authors:  Koichiro Tsukasa; Qiang Ding; Yumi Miyazaki; Shyuichiro Matsubara; Shoji Natsugoe; Sonshin Takao
Journal:  Hum Cell       Date:  2016-03-10       Impact factor: 4.174

Review 10.  MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.

Authors:  Wei Wang; Yun-ping Luo
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.